Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the safety and efficacy of ranibizumab to treat
non-arteritic ischemic optic neuropathy based on clinical and anatomical findings.